Temperature-sensitive polymer-coated magnetic nanoparticles as a potential drug delivery system for targeted therapy of thyroid cancer

Journal of Biomedical Nanotechnology

Volumn 8, Issue 6, 2012, Pages 983-990

  Koppolu, Bhanuprasanth ^a,b   Bhavsar, Zarna ^a,b   Wadajkar, Aniket S ^a,b   Nattama, Sivaniarvindpriya ^a,b   Rahimi, Maham ^a,b   Nwariaku, Fiemu ^c   Nguyen, Kytai T ^a,b  

^a The University of Texas at Arlington   (United States)

^b The University of Texas Southwestern Medical Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Magnetic nanoparticles; On off drug release; Temperature Responsive polymers; Thyroid cancer

Indexed keywords

CANCER CELLS; DOSE-DEPENDENT MANNER; DOXORUBICIN; DRUG CARRIER; DRUG LOADING; DRUG RELEASE; EXTERNAL MAGNETIC FIELD; IN-VITRO; IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLES; PHYSIOLOGICAL FLOW; POTENTIAL DRUG; TEMPERATURE RESPONSIVE POLYMERS; TEMPERATURE-RESPONSIVE RELEASE; TEMPERATURE-SENSITIVE; THYROID CANCERS;

ACRYLIC MONOMERS; AMIDES; DISEASES; DRUG DELIVERY; FREE RADICAL POLYMERIZATION; HYDROGELS; IRON OXIDES; LOADING; POLYMERS;

NANOPARTICLES;

DOXORUBICIN; DRUG CARRIER; FREE RADICAL; IRON OXIDE; MAGNETIC NANOPARTICLE; NANOCOATING; POLYMER; SILANE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ADVANCED CANCER; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; MAGNETIC FIELD; POLYMERIZATION; TEMPERATURE SENSITIVITY; THYROID CANCER;

CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; MAGNETIC FIELDS; MAGNETICS; NANOPARTICLES; POLYMERS; TEMPERATURE; THYROID NEOPLASMS; TIME FACTORS;

EID: 84865310340     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1465     Document Type: Article

References (32)

1. L. D. Green, L. Mack, and J. L. Pasieka, Anaplastic thyroid cancer and primary thyroid lymphoma: A review of these rare thyroid malignancies. J. Surg. Oncol. 94, 725 (2006).
2. B. A. Kenneth, Anaplastic thyroid carcinoma: A therapeutic challenge. Seminars in Surgical Oncology 16, 64 (1999).
3. C. Schmutzler and J. Koehrle, Innovative strategies for the treatment of thyroid cancer. Eur. J. Endocrinol. 143, 15 (2000).
4. S. M. Wiseman, T. R. Loree, N. R. Rigual, W. L. Hicks, Jr., W. G. Douglas, G. R. Anderson, and D. L. Stoler, Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 25, 662 (2003).
5. D. R. Crevoisier, E. Baudin, A. Bachelot, S. Leboulleux, J. P. Travagli, B. Caillou, and M. Schlumberger, Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyper-fractionated accelerated external radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 60, 1137 (2004).
6. F. Furuya, H. Shimura, H. Suzuki, K. Taki, K. Ohta, K. Haraguchi, T. Onaya, T. Endo, and T. Kobayashi, Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin. Endocrinology 145, 2865 (2004).
7. D. Giuffrida and H. Gharib, Anaplastic thyroid carcinoma: Current diagnosis and treatment. Annals of Oncology 11, 1083 (2000).
8. C. Corot, P. Robert, J. M. Idee, and M. Port, Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58, 1471 (2006).
9. Y. X. Wang, S. M. Hussain, and G. P. Krestin, Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11, 2319 (2001).
10. M. Chorny, I. Fishbein, B. B. Yellen, I. S. Alferiev, M. Bakay, S. Ganta, R. Adamo, M. Amiji, G. Friedman, and R. J. Levy, Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc. Natl. Acad. Sci. USA 107, 8346 (2010).
11. J. Dobson, Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene. Ther. 13, 283 (2006).
12. F. Gazeau, M. Levy, and C. Wilhelm, Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine (Lond) 3, 831 (2008).
13. S. C. McBain, H. H. Yiu, and J. Dobson, Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 3, 169 (2008).
14. A. K. Gupta, R. R. Naregalkar, V. D. Vaidya, and M. Gupta, Recent advances on surface engineering of magnetic iron oxide nano-particles and their biomedical applications. Nanomed. 2, 23 (2007).
15. M. Rahimi, S. Kilaru, G. E. Sleiman, A. Saleh, D. Rudkevich, and K. Nguyen, Synthesis and characterization of thermo-sensitive nanoparticles for drug delivery applications. J. Biomed. Nanotechnol. 4, 482 (2008).
16. B. Koppolu, M. Rahimi, S. Nattama, A. Wadajkar, and K. T. Nguyen, Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomedicine 6, 355 (2010).
17. M. Rahimi, E. I. Meletis, S. You, and K. Nguyen, Formulation and characterization of novel temperature sensitive polymer-coated magnetic nanoparticles. J. Nanosci. Nanotechnol. 10, 6072 (2010).
18. M. Rahimi, A. Wadajkar, K. Subramanian, M. Yousef, W. Cui, J. T. Hsieh, and K. T. Nguyen, In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine 6, 672 (2010).
19. J. H. Hwang, J. H. Hwang, H. K. Chung, D. W. Kim, E. S. Hwang, J. M. Suh, H. Kim, K.-H. You, O.-Y. Kwon, H. K. Ro, D. Y. Jo, and M. Shong, CXC Chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J. Clin. Endocrinol. Metab. 88, 408 (2003).
20. A. Lin, A. Sabnis, S. Kona, S. Nattama, H. Patel, J. F. Dong, and K. T. Nguyen, Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. J. Biomed. Mater. Res. A 93, 833 (2010).
21. P. Haigh, Anaplastic thyroid carcinoma. Current Treatment Options in Oncology 1, 353 (2000).
22. J. Tennvall, G. Lundell, P. Wahlberg, A. Bergenfelz, L. Grimelius, M. Akerman, A. L. H. Skog, and G. Wallin, Anaplastic thyroid carcinoma: Three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br. J. Cancer 86, 1848
23. C. Sun, J. S. Lee, and M. Zhang, Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 60, 1252 (2008).
24. Q. Zhang, M. S. Thompson, A. Y. Carmichael-Baranauskas, B. L. Caba, M. A. Zalich, Y. N. Lin, O. T. Mefford, R. M. Davis, and J. S. Riffle, Aqueous dispersions of magnetite nanoparticles complexed with copolyether dispersants: Experiments and theory. Langmuir 23, 6927 (2007).
25. A. Hofmann, D. Wenzel, U. M. Becher, D. F. Freitag, A. M. Klein, D. Eberbeck, M. Schulte, K. Zimmermann, C. Bergemann, B. Gleich, W. Roell, T. Weyh, L. Trahms, G. Nickenig, B. K. Fleischmann, and A. Pfeifer, Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nano-particles. Proc. Natl. Acad. Sci. USA 106, 44 (2009).
26. C.-A. M. Smith, J. D. L. Fuente, B. Pelaz, E. P. Furlani, M. Mullin, and C. C. Berry, The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. Biomaterials 31, 4392 (2010).
27. B. Zebli, A. S. Susha, G. B. Sukhorukov, A. L. Rogach, and W. J. Parak, Magnetic targeting and cellular uptake of polymer microcapsules simultaneously functionalized with magnetic and luminescent nanocrystals. Langmuir 21, 4262 (2005).
28. L. Dini and L. Abbro, Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 36, 195 (2005).
29. J. Miyakoshi, Effects of static magnetic fields at the cellular level. Prog. Biophys. Mol. Biol. 87, 213 (2005).
30. C. Alexiou, A. Schmidt, R. Klein, P. Hulin, C. Bergemann, and W. Arnold, Magnetic drug targeting: Biodistribution and dependency on magnetic field strength. J. Magn. Magn. Mater. 252, 363 (2002).
31. S. B. Christopher and A. P. Nikolaos, Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co- methacrylic acid) hydrogels. J. controlled release 39, 57 (1996).
32. G. P. Tae, Temperature modulated protein release from pH/temperaturesensitive hydrogels. Biomaterials 20, 517 (1999).